Eight cases (13.6%) of BPH showed negative SRD5A2 expression, 17 cases (28.8%) showed weak expression, and 34 cases (57.6%) showed strong positive expression (Fig. 1 A, B). The gene discussed is SRD5A2; the disease is benign prostatic hyperplasia.